Cochlear Limited
File:Cochlear Limited Logo.jpeg | |
Public | |
Traded as | ASX: COH |
Industry | Biotechnology |
Founded | 1981 |
Headquarters | Sydney, Australia |
Key people
|
Chris Smith (CEO) Rick Holliday-Smith (Chairman) |
Products | Cochlear implants Bone-anchored hearing aids Cochlear wireless accessories Bone anchored prosthetics |
Revenue | ![]() |
![]() |
|
Number of employees
|
2,800 in 20 countries (2015)[1] |
Website | www.cochlear.com |
Cochlear (ASX: COH) is a global biotechnology company that designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.[2]
Based in Sydney, Cochlear was formed in 1981 with finance from the Australian government to commercialise the implants pioneered by Dr Graeme Clark.[3][4] Today, the company holds over two-thirds of the worldwide hearing implant market,[5][6] with more than 250,000 people receiving one of Cochlear's implants since 1982.[2]
Cochlear was named Australia's most innovative company in 2002 and 2003,[7] and one of the world's most innovative companies by Forbes in 2011.[8]
Products
Cochlear produces three implants for different medical situations.
Nucleus is a system combining an electrical simulation device that is surgically implanted behind a patient's ear, a processor that captures sounds, and an electrode array that relays the sounds to the brain.[2][9] It is a direct descendant of the original cochlear implants, also known as Nucleus, developed by Dr Graeme Clark in Melbourne during the 1970s.[3] Nucleus was the first cochlear implant to be approved by the U.S. Food and Drug Administration.[10] The system is upgradable, for example by installing a new sound processor, without surgery.[2] Cochlear's latest processor, Nucleus 6, was launched in 2013 after six years of development.[11] In 2013, the Nucleus implant recorded 99% reliability over the last 8 years, more than any similar product.[12]
Hybrid is an electro-acoustic system combining a cochlear implant with an acoustic hearing aid, suitable for patients who have residual hearing at low frequencies.[13] The implant of the Hybrid system is a smaller variant of Nucleus, with an electrode that relays only high frequency sounds,[13] while the acoustic component amplifies low frequency sounds and transmits them to the brain through the ordinary nerve pathway.[2] Hybrid was launched in 2008 and won Australian Engineering Excellence and International Design Awards in 2009.[13]
Baha (derived from bone anchored hearing aid) is a bone conduction system involving a small titanium implant that is ossointegrated with the bone behind a patient's ear.[2] A sound processor captures sounds, which is passed to the implant and directly transferred to the inner ear through the skull.[2][14] Baha was originally produced by Swedish biotechnology group Entific Medical Systems before that company was acquired by Cochlear in 2005.[15]
Corporate Affairs
Cochlear manufactures principally in Sweden and Australia, including at a purpose-built facility at Macquarie University in Sydney.[16][17] The company's products are supplied to over 100 countries internationally, with 43% sales revenue ($403 million) derived from the Americas, 40% ($377.6 million) from Europe, the Middle East and Africa and 17% ($161.3 million) from the Asia-Pacific region as of 2015.[2] Cochlear spent $128 million on research and development in FY15.[2]
In 2011, reports arose of Nucleus model CI500 implants shutting down, although less than 1% of devices were affected and the failures posed no health risks.[18][19] Cochlear funded a complete recall of the model, with an older version of the Nucleus implant being available as a replacement.[18][19] The company spent $101.3 million on the recall.[20]
References
- ↑ 1.0 1.1 1.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 13.0 13.1 13.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 18.0 18.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 19.0 19.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
See also
- Use Australian English from June 2013
- All Wikipedia articles written in Australian English
- Use dmy dates from June 2013
- Pages with broken file links
- Biotechnology companies of Australia
- Manufacturing companies of Australia
- Companies listed on the Australian Securities Exchange
- Companies based in Sydney
- Hearing aid manufacturers